about
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trialThe role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trialAnalysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparumProcess development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparumPurification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coliPurification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coliTowards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.Plasma advanced oxidative protein products are associated with anti-oxidative stress pathway genes and malaria in a longitudinal cohort.Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western KenyaInterleukin-10 (IL-10) polymorphisms are associated with IL-10 production and clinical malaria in young children.Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoitesPlasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique.Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique.Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.Comparison of commercial kits to measure cytokine responses to Plasmodium falciparum by multiplex microsphere suspension array technology.Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to Glycophorin A.Blood oxidative stress markers and Plasmodium falciparum malaria in non-immune African children.Does infection with Human Immunodeficiency Virus affect the antibody responses to Plasmodium falciparum antigenic determinants in asymptomatic pregnant women?Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.IgM and IgG against Plasmodium falciparum lysate as surrogates of malaria exposure and protection during pregnancy.High production of pro-inflammatory cytokines by maternal blood mononuclear cells is associated with reduced maternal malaria but increased cord blood infection.Cord Blood IL-12 Confers Protection to Clinical Malaria in Early Childhood Life
P50
Q28254031-AED25B76-6B66-4A72-AEB9-CCD89FD03635Q28731458-A387D8F9-8A55-43B0-BE71-9EBD9AA494B2Q33591313-5488435D-D472-4971-86E3-61AFD44CFBE8Q33769381-938ACB6E-8AE2-4A3A-8885-3DBE6AA5AB52Q34008897-025D827E-8A23-4596-BFE8-D08EC6BDE0AFQ34122492-705E4359-4E40-4BAD-9483-578EEC8A25DDQ34401225-2BFDFA99-0188-47CB-A14A-660389716ED3Q34501444-B7631AF8-437F-4EC5-8EA2-381E54E4B6D1Q35550197-F41F647D-3C5F-43D9-933B-095BFF2C5769Q36156014-D15ED9C4-B2B2-460D-A77A-75275576B085Q36349656-15AE8CFE-46FC-4C54-9CE9-8EA44A415576Q37355917-B080F265-454E-470D-8EF1-67A04DB5D01BQ37702603-F5A71F07-7F0F-4117-8B93-F94C2DEE2FAEQ40144102-94AF8E5D-0372-44AE-9089-EAE7A5FF4C90Q41896063-82CDA776-1CDF-41DF-836F-A27C37A3C528Q42727356-1ECBBF41-F73F-4B73-8041-656EDA10881BQ43545546-D4476729-5374-404A-B5C7-6A05DBB6257CQ43646009-96EBEDF1-B582-485A-9F94-0FFDF23DF326Q43838060-922525B5-B819-4A61-951E-AF8C07C184C7Q47904576-CD37A003-AB9C-4DE6-9633-FEA0AD9A77A3Q53819699-2B4276B6-5A09-4784-8096-3863279483F7Q53819703-E3DE6F57-98AF-46DA-B1FD-B48707CEEA90Q56361624-F5DFA8D1-1D95-47BE-990A-5B9F84C64BAE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Arnoldo Barbosa
@ast
Arnoldo Barbosa
@en
Arnoldo Barbosa
@es
Arnoldo Barbosa
@nl
type
label
Arnoldo Barbosa
@ast
Arnoldo Barbosa
@en
Arnoldo Barbosa
@es
Arnoldo Barbosa
@nl
altLabel
Arnoldo Barbosa Ramírez
@en
prefLabel
Arnoldo Barbosa
@ast
Arnoldo Barbosa
@en
Arnoldo Barbosa
@es
Arnoldo Barbosa
@nl
P106
P1153
7103244703
P21
P31
P496
0000-0001-8652-7396